Literature DB >> 2382894

Effects of propranolol on arterial oxygenation and oxygen transport to tissues in patients with cirrhosis.

A G Agusti1, J Roca, J Bosch, J C Garcia-Pagan, P D Wagner, R Rodriguez-Roisin.   

Abstract

Patients with cirrhosis may show ventilation-perfusion (VA/Q) inequality in the absence of any intrinsic heart or lung disease. However, the high cardiac output of cirrhosis generally prevents or minimizes the appearance of a severe degree of arterial hypoxemia. Propranolol has been used to reduce cardiac output and portal pressure in these patients. We wondered whether it might alter arterial oxygenation and reduce O2 transport to tissues. We studied eight patients (three women) 54 +/- 3 (SEM) yr of age before and after intravenous propranolol (0.1 mg/kg followed by 2 mg/h). Cardiac output (QT) fell from 7.8 +/- 0.7 to 6.0 +/- 0.7 L/min (p less than 0.05), and portal pressure was reduced (22 +/- 2 to 19 +/- 2 mm Hg, p less than 0.01). Arterial PO2 did not change (88 +/- 4 to 89 +/- 5 mm Hg) because the fall in mixed venous PO2 (43 +/- 1 to 40 +/- 1 mm Hg, p less than 0.01) that followed the lower QT was counterbalanced by a lower intrapulmonary shunt (multiple inert gas technique) (4 +/- 2 to 2 +/- 1%, p less than 0.05) and a shift of the VA/Q distributions toward a higher VA/Q ratio. Paralleling the fall in QT, oxygen transport to tissues (QO2) was reduced (19 +/- 2 to 14 +/- 1 ml/min/kg, p less than 0.01). However, O2 uptake (VO2) remained constant (3.4 +/- 0.2 to 3.6 +/- 0.2 ml/min/kg) because O2 extraction by the tissues increased appropriately (22 +/- 2 to 28 +/- 1%, p less than 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2382894     DOI: 10.1164/ajrccm/142.2.306

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  4 in total

1.  The hepatopulmonary syndrome: new name, old complexities.

Authors:  R Rodríguez-Roisin; A G Agustí; J Roca
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

2.  Analysis of impaired exercise capacity in patients with cirrhosis.

Authors:  S K Epstein; R L Ciubotaru; M D Zilberberg; L M Kaplan; C Jacoby; R Freeman; M M Kaplan
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

3.  Impact of mild and moderate intrapulmonary shunting in children with end-stage liver disease undergoing liver transplantation.

Authors:  Chi-Di Liang; Sheung-Fat Ko; Chao-Long Chen; Allan M Concejero
Journal:  World J Surg       Date:  2007-05-16       Impact factor: 3.352

4.  Liver epigenome changes in patients with hepatopulmonary syndrome: A pilot study.

Authors:  Nuria Mendoza; Eva Rivas; Roberto Rodriguez-Roisin; Tamara Garcia; Miquel Bruguera; Alvar Agusti; Rosa Faner
Journal:  PLoS One       Date:  2021-02-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.